Sökning: WFRF:(Friesland Signe) > Differences in heal...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07147naa a2200757 4500 | |
001 | oai:DiVA.org:uu-296786 | |
003 | SwePub | |
008 | 160620s2016 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:umu-120668 | |
009 | oai:lup.lub.lu.se:0cab5c64-6254-4218-a4cb-a967c219a119 | |
009 | oai:prod.swepub.kib.ki.se:133325023 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2967862 URI |
024 | 7 | a https://doi.org/10.1016/j.radonc.2015.12.0242 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1206682 URI |
024 | 7 | a https://lup.lub.lu.se/record/85773282 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1333250232 URI |
040 | a (SwePub)uud (SwePub)umud (SwePub)lud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Nyqvist, Johannau Umeå universitet,Öron- näs- och halssjukdomar,Department of Otolaryngology and Head and Neck Surgery, Skåne University Hospital, Lund4 aut0 (Swepub:lu)med-jnq |
245 | 1 0 | a Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up |
264 | 1 | b Elsevier BV,c 2016 |
338 | a print2 rdacarrier | |
520 | a Background and purpose: Health related quality of life (HRQoL) was assessed in the randomised, prospective ARTSCAN study comparing conventional radiotherapy (CF) with accelerated radiotherapy (AF) for head and neck cancer. Material and methods: 750 patients with squamous cell carcinoma (of any grade and stage) in the oral cavity, oro-, or hypopharynx or larynx (except T1-2, NO glottic carcinoma) without distant metastases were randomised to either conventional fractionation (2 Gy/day, 5 days/week in 49 days, total dose 68 Gy) or accelerated fractionation (1.1 + 2.0 Gy/day, 5 days/week in 35 days, total dose 68 Gy). HRQoL was assessed with EORTC QLQ-C30, QLQ-H&N35 and HADS at baseline, at end of radiotherapy (eRT) and at 3 and 6 months and 1, 2 and 5 years after start of treatment. Results: The AF group reported HRQoL was significantly lower at eRT and at 3 months for most symptoms, scales and functions. Few significant differences were noted between the groups at 6 months and 5 years. Scores related to functional oral intake never reached baseline. Conclusion: In comparison to CF, AF has a stronger adverse effect on HRQoL in the acute phase. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Radiologi och bildbehandling0 (SwePub)302082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Radiology, Nuclear Medicine and Medical Imaging0 (SwePub)302082 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Omvårdnad0 (SwePub)303052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nursing0 (SwePub)303052 hsv//eng |
653 | a Health related quality of life | |
653 | a Accelerated radiotherapy | |
653 | a Head and neck cancer | |
653 | a Quality of life | |
653 | a Accelerated fractionation | |
700 | 1 | a Fransson, Peru Umeå University,Umeå universitet,Institutionen för omvårdnad4 aut0 (Swepub:umu)perfrn96 |
700 | 1 | a Laurell, Göranu Umeå University,Umeå universitet,Uppsala universitet,Öron-, näs- och halssjukdomar,Umea Univ, Dept Clin Sci Otolaryngol & Head & Neck Surg, S-90187 Umea, Sweden.,Öron- näs- och halssjukdomar,Department of Otolaryngology and Head and Neck Surgery, Uppsala University Hospital4 aut0 (Swepub:umu)gala0001 |
700 | 1 | a Hammerlid, Evau Sahlgrens Univ Hosp, Dept Otolaryngol & Head & Neck Surg, Gothenburg, Sweden.,Sahlgrenska University Hospital4 aut |
700 | 1 | a Kjellén, Elisabethu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital4 aut0 (Swepub:lu)onk-ekj |
700 | 1 | a Franzén, Larsu Umeå University,Umeå universitet,Onkologi4 aut0 (Swepub:umu)lafr0004 |
700 | 1 | a Söderström, Karinu Umeå University,Umeå universitet,Onkologi4 aut0 (Swepub:umu)kansom97 |
700 | 1 | a Wickart-Johansson, Gunu Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden.,Karolinska University Hospital4 aut |
700 | 1 | a Friesland, Signeu Karolinska Institutet4 aut |
700 | 1 | a Sjodin, Helenau Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden.,Karolinska University Hospital4 aut |
700 | 1 | a Brun, Evau Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital4 aut0 (Swepub:lu)onk-ebr |
700 | 1 | a Ask, Andersu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital4 aut0 (Swepub:lu)onk-aas |
700 | 1 | a Nilsson, Peru Lund University,Lunds universitet,Medicinsk strålningsfysik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical Radiation Physics, Lund,Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital4 aut0 (Swepub:lu)rafy-per |
700 | 1 | a Ekberg, Larsu Lund Univ, Skane Univ Hosp, Dept Oncol & Radiat Phys, S-22100 Lund, Sweden.,Skåne University Hospital4 aut |
700 | 1 | a Bjork-Eriksson, Thomasu Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden.4 aut |
700 | 1 | a Nyman, Janu Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden.4 aut |
700 | 1 | a Loden, Brittau Karlstad Cent Hosp, Dept Clin Oncol, Karlskrona, Sweden.4 aut |
700 | 1 | a Lewin, Freddiu Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden.4 aut |
700 | 1 | a Reizenstein, Johanu Orebro Univ Hosp, Dept Oncol, Orebro, Sweden.4 aut |
700 | 1 | a Lundin, Eriku Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden.4 aut |
700 | 1 | a Zackrisson, Björnu Umeå universitet,Onkologi4 aut0 (Swepub:umu)bjza0002 |
710 | 2 | a Umeå universitetb Öron- näs- och halssjukdomar4 org |
773 | 0 | t Radiotherapy and Oncologyd : Elsevier BVg 118:2, s. 335-341q 118:2<335-341x 0167-8140x 1879-0887 |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/26777124?dopt=Abstracty FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1016/j.radonc.2015.12.024y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-296786 |
856 | 4 8 | u https://doi.org/10.1016/j.radonc.2015.12.024 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-120668 |
856 | 4 8 | u https://lup.lub.lu.se/record/8577328 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:133325023 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy